Weave Communications to Be Acquired by Francisco Partners for $650 Million
Weave Communications will be acquired by Francisco Partners for $650 million. Shareholders receive $7.40 per share in cash, a 34% premium.
NOTRELOAD AI
Haemonetics Lands Non-Exclusive Deal with Major Plasma Collector CSL
Haemonetics enters a non-exclusive supply deal with CSL Plasma for NexSys PCS devices with Persona PLUS technology and disposables in the U.S.
Nuvation Bio: JPMorgan Sees Strong Ibtrozi Launch and Pipeline Upside
JPMorgan initiates Nuvation Bio at Overweight with $13 target, citing durable first-line adoption of Ibtrozi in ROS1+ lung cancer.
Klarna Q2 Profit Beat Overshadowed by Trimmed Volume Forecast and Leadership Changes
Klarna shares dropped after trimming full-year GMV guidance, despite a strong Q2 profit of $9M, 27% revenue growth, and higher margins.
Amylyx Drug Cuts Dangerous Low Blood Sugar Episodes After Weight-Loss Surgery in Key Trial
Amylyx’s avexitide reduced severe low blood sugar episodes by 55% in a Phase 3 trial for post-bariatric hypoglycemia. First potential treatment nears FDA filing.
Kura Oncology Insider Buy: CEO Adds $1.11M Stake as Cash Runway Stretches to 2028
Kura Oncology CEO Troy Wilson bought 100K shares for $1.11M on Aug 17, 2026. Open-market buy follows KOMZIFTI sales and cash runway to 2028.